Cargando…
SARS-CoV-2 Infection in Hereditary Hemorrhagic Telangiectasia Patients Suggests Less Clinical Impact Than in the General Population
At the moment of writing this communication, the health crisis derived from the COVID-19 pandemic has affected more than 120 million cases, with 40 million corresponding to Europe. In total, the number of deaths is almost 3 million, but continuously rising. Although COVID-19 is primarily a respirato...
Autores principales: | Marcos, Sol, Albiñana, Virginia, Recio-Poveda, Lucia, Tarazona, Belisa, Verde-González, María Patrocinio, Ojeda-Fernández, Luisa, Botella, Luisa-María |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123859/ https://www.ncbi.nlm.nih.gov/pubmed/33925423 http://dx.doi.org/10.3390/jcm10091884 |
Ejemplares similares
-
Research on potential biomarkers in hereditary hemorrhagic telangiectasia
por: Botella, Luisa-María, et al.
Publicado: (2015) -
Review of Pharmacological Strategies with Repurposed Drugs for Hereditary Hemorrhagic Telangiectasia Related Bleeding
por: Albiñana, Virginia, et al.
Publicado: (2020) -
Mutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1
por: Albiñana, Virginia, et al.
Publicado: (2017) -
Copy number variations in endoglin locus: mapping of large deletions in Spanish families with hereditary hemorrhagic telangiectasia type 1
por: Fontalba, Ana, et al.
Publicado: (2013) -
Mutation study of Spanish patients with Hereditary Hemorrhagic Telangiectasia
por: Fontalba, Ana, et al.
Publicado: (2008)